Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-24 @ 11:32 PM
NCT ID:
NCT00066456
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of ovarian, peritoneal, or fallopian tube carcinoma
* Radiographic, clinical, or pathologic evidence of relapse
* Recurrent or persistent disease after chemotherapy (may be enrolled at first or subsequent relapse)
* Received prior taxane OR platinum agent
* Performance status - GOG 0-1
* WBC at least 3,000/mm\^3
* Absolute neutrophil count at least 1,500/mm\^3
* Platelet count at least 100,000/mm\^3
* Bilirubin no greater than 1.5 times upper limit of normal (ULN)
* SGOT/SGPT no greater than 2.5 times ULN
* Alkaline phosphatase no greater than 2.5 times ULN
* Creatinine no greater than 1.5 times ULN
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception
* No grade 2 or greater neuropathy (sensory or motor)
* No septicemia
* No severe infection
* No circumstance that would preclude study completion
* No prior radiotherapy to the abdomen or pelvis
* Patients with ureteral obstruction must undergo stent or nephrostomy tube replacement prior to study entry
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00066456
Study Brief:
Protocol Section:
NCT00066456